Home/Personalis/Michael Snyder
MS

Michael Snyder

Chairman of the Scientific Advisory Board & Co-founder

Personalis

Therapeutic Areas

Personalis Pipeline

DrugIndicationPhase
NeXT Personal®Molecular Residual Disease (MRD) Detection & Monitoring in Solid TumorsCommercial
ImmunoID NeXT Platform®Comprehensive Genomic Profiling for Therapy Selection & Biomarker DiscoveryCommercial
Personalis ACE ImmunoID AssayTumor Mutational Burden (TMB) & Microsatellite Instability (MSI) TestingCommercial
MRD Detection in Hematologic MalignanciesMRD for Leukemia, Lymphoma, Multiple MyelomaDevelopment
Early Cancer DetectionMulti-Cancer Early Detection (MCED)Research